Stem Cell‐Based Cancer Therapies: A Commentary on Therapeutic Promise, Health Impacts and Translational Barriers
Stem cell-based cancer therapies offer novel mechanisms for tumour targeting, immune modulation and tissue repair, with applications from haematopoietic to induced pluripotent stem cells. While showing strong therapeutic promise, their clinical translation is hindered by ethical, regulatory and economic barriers. Coordinated global action is essential to unlock their full potential in oncology.
Authors
- Long Chiau Ming (ORCID: https://orcid.org/0000-0002-6971-1383)
- Bey Hing Goh (ORCID: https://orcid.org/0000-0003-1006-3649)
- Rachel Wong (ORCID: https://orcid.org/0000-0002-4926-5689)
- Nancy Choon‐Si Ng (ORCID: https://orcid.org/0000-0003-2225-7678)
- Zar Soe Thin
Institutions
- University of Technology Sydney (AU)
- Sunway University (MY)
Publication Details
- Journal
- Cancer Innovation
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1002/cai2.70025
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Technology Sydney